What Is GHK-Cu?
GHK-Cu (glycine-histidine-lysine copper complex) is a naturally occurring tripeptide-copper(II) chelate first isolated from human plasma by Loren Pickart in 1973. Present at high concentrations in blood, saliva, and urine in youth (~200 ng/mL at age 20), serum GHK levels decline markedly with age (~80 ng/mL by age 60), a pattern that has led geroscience researchers to study GHK-Cu as a potential mediator of the aging-related decline in tissue repair capacity.
GHK-Cu has accumulated an unusually broad research profile across dermatology, wound healing, neuroscience, and aging biology, making it one of the most versatile research peptides available. Over 50 published studies document its biological activities across multiple tissue types.
Mechanism of Action
- Collagen Synthesis: Upregulates collagen I, III, and IV production in fibroblasts; activates collagen-encoding genes via TGF-β pathway modulation
- Matrix Metalloproteinase Regulation: Promotes remodeling balance — increases MMP activity while also inducing TIMP (tissue inhibitor of metalloproteinase) expression
- Growth Factor Modulation: Amplifies effects of TGF-β1, FGF, VEGF, and NGF in tissue repair models
- Antioxidant Activity: Copper cofactor contributes superoxide dismutase-like activity; reduces 8-OHdG DNA oxidation markers
- Anti-inflammatory: Inhibits NF-κB activation and downregulates TNF-α, IL-6, and IL-1β production
- Gene Expression: A 2009 microarray analysis (Pickart et al.) found GHK-Cu modulates over 4,000 human genes — activating wound repair genes and suppressing inflammatory and cancer-related gene expression
- Neurotrophin Support: Increases NGF and BDNF expression in neural tissue models
Research Applications and Data
Wound Healing
- Accelerated wound closure by 20–30% in rodent excision wound models
- Enhanced granulation tissue formation and re-epithelialization rate
- Improved collagen deposition quality (increased collagen cross-linking density)
Skin Aging and Dermatology
- Increased skin thickness and elasticity in human clinical studies (Leyden et al.)
- Improved photoaging scores including fine lines, wrinkle depth, and skin density
- Reduced hyperpigmentation and improved skin texture in clinical assessments
Hair Follicle Research
- Stimulates hair follicle enlargement and elongation in organ culture models
- Increases keratinocyte proliferation in follicular epithelium
- Shifts follicle cycling toward the anagen (growth) phase in mouse models
Neuroscience Applications
- NGF upregulation supports peripheral nerve regeneration models
- BDNF effects documented in hippocampal cell culture studies
- Neuroprotective effects against oxidative stress-induced neuronal death
Aging and Longevity Research
- Downregulates “cancer-like” and “inflammation-like” gene expression clusters in aged tissues
- Reverses many age-associated gene expression changes in human fibroblasts in vitro
- Increases Nrf2 target gene expression, activating endogenous antioxidant programs
Dosage Reference for Research
| Research Context | Concentration / Dose | Route |
|---|---|---|
| In vitro fibroblast studies | 1–100 nM | Cell culture media |
| Wound healing (rodent) | 1–10 µg/cm² wound area | Topical or SC peri-wound |
| Hair follicle organ culture | 10–1000 nM | Culture media |
| Human clinical (skin aging) | 0.1–1% topical formulation | Topical |
Where to Buy GHK-Cu for Research
Sourcing criteria for research-grade GHK-Cu:
- HPLC purity ≥99% to confirm copper-peptide complex integrity
- Mass spectrometry verification of the Cu²⁺ chelate (not free peptide alone)
- Endotoxin testing for cell culture applications
- Lyophilized powder for long-term stability; reconstitute in aqueous buffer for in vitro use

HPLC Verified
Research Disclaimer: This product is sold strictly for in vitro research and laboratory use only. Not for human consumption. Not medical advice.